These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 19148473
1. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas. Iliopoulos D, Satra M, Drakaki A, Poultsides GA, Tsezou A. Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473 [Abstract] [Full Text] [Related]
2. Telomerase and c-myc expression in hepatocellular carcinomas. Liu YC, Chen CJ, Wu HS, Chan DC, Yu JC, Yang AH, Cheng YL, Lee SC, Harn HJ. Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891 [Abstract] [Full Text] [Related]
3. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G. Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366 [Abstract] [Full Text] [Related]
4. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ. Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [Abstract] [Full Text] [Related]
5. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, Yoo HS, Choi JY, Bae YS, Yeom YI. Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433 [Abstract] [Full Text] [Related]
6. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T, Shiratori Y. J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538 [Abstract] [Full Text] [Related]
7. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M, Gatselis N, Iliopoulos D, Zacharoulis D, Dalekos GN, Tsezou A. J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [Abstract] [Full Text] [Related]
8. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Atkinson SP, Hoare SF, Glasspool RM, Keith WN. Cancer Res; 2005 Sep 01; 65(17):7585-90. PubMed ID: 16140922 [Abstract] [Full Text] [Related]
9. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC. Cancer Res; 1999 Dec 15; 59(24):6087-90. PubMed ID: 10626795 [Abstract] [Full Text] [Related]
10. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma. Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW. Cancer; 2006 Aug 01; 107(3):579-90. PubMed ID: 16795071 [Abstract] [Full Text] [Related]
11. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. Zhang PH, Zou L, Tu ZG. J Surg Res; 2006 Mar 01; 131(1):143-9. PubMed ID: 16298398 [Abstract] [Full Text] [Related]
12. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. Zhang C, Guo X, Zhang L, Lu Z, Ma N, Cheng Y, Shen F, Zhang B, Wu M, Wei L. J Surg Oncol; 2008 Nov 01; 98(6):462-8. PubMed ID: 18683194 [Abstract] [Full Text] [Related]
14. Abnormal expression of hepatomas and circulating telomerase and its clinical values. Wu W, Yao DF, Qiu LW, Wu XH, Yao M, Su XQ, Zou L. Hepatobiliary Pancreat Dis Int; 2005 Nov 01; 4(4):544-9. PubMed ID: 16286259 [Abstract] [Full Text] [Related]
15. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M. Int J Oncol; 2008 Nov 01; 33(5):949-58. PubMed ID: 18949357 [Abstract] [Full Text] [Related]
16. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A. Liver Int; 2005 Apr 01; 25(2):380-8. PubMed ID: 15780064 [Abstract] [Full Text] [Related]
17. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma. Choi JH, Park SH, Park J, Park BG, Cha SJ, Kong KH, Lee KH, Park AJ. Biochem Biophys Res Commun; 2007 Sep 28; 361(3):615-20. PubMed ID: 17673177 [Abstract] [Full Text] [Related]
18. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. Yeh SH, Wu DC, Tsai CY, Kuo TJ, Yu WC, Chang YS, Chen CL, Chang CF, Chen DS, Chen PJ. Clin Cancer Res; 2006 Feb 15; 12(4):1097-108. PubMed ID: 16489062 [Abstract] [Full Text] [Related]
20. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Liu C, Fang X, Ge Z, Jalink M, Kyo S, Björkholm M, Gruber A, Sjöberg J, Xu D. Cancer Res; 2007 Mar 15; 67(6):2626-31. PubMed ID: 17363582 [Abstract] [Full Text] [Related] Page: [Next] [New Search]